EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation

Clinical trial NCT07438067 · RECRUITING

Trial details

NCT number: NCT07438067
Sponsor: Daihong Liu
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

EBV-DNA Viremia

Start date: 2025-03-26
Primary completion: 2028-03-26
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.